ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,361Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 586

$507K Total Retail Price of All Prescriptions

Rank: 23 out of 586

360 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 360 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

25% of this provider’s 360 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 7,422 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
HYDROCODONE-ACETAMINOPHEN 754 316 S3 1 5
LEVOTHYROXINE SODIUM 581 466 2 2
OMEPRAZOLE 449 318 3 3
TRAMADOL HCL 367 215 4 15
METFORMIN HCL 334 214 5 6
LISINOPRIL 268 183 6 4
LOSARTAN POTASSIUM 245 199 7 18
FUROSEMIDE 245 186 7 9
CITALOPRAM HBR 237 199 9 12
SIMVASTATIN 234 187 10 1
WARFARIN SODIUM 212 187 11 13
PRAVASTATIN SODIUM 210 153 12 22
ZOLPIDEM TARTRATE 156 98 13 8
POTASSIUM CHLORIDE 149 126 14 14
AMLODIPINE BESYLATE 137 129 15 7
HYDROCHLOROTHIAZIDE 136 106 16 10
GABAPENTIN 118 75 17 11
ROPINIROLE HCL 111 62 18 95
NABUMETONE 100 56 19 99
LOSARTAN-HYDROCHLOROTHIAZIDE 98 82 20 31
KLOR-CON M10 97 81 21 170
TRAZODONE HCL 92 30 22 20
AZITHROMYCIN 85 56 23 36
OXYCODONE-ACETAMINOPHEN 84 34 S2 24 78
CYMBALTA 83 50 25 29
LEVOFLOXACIN 82 44 26 146
ATENOLOL 80 50 27 34
NEXIUM 79 51 28 51
SERTRALINE HCL 78 40 29 21
SYNTHROID 78 55 29 45
AMITRIPTYLINE HCL 76 20 R 31 62
ALENDRONATE SODIUM 75 65 32 23
SINGULAIR 74 47 33 173
PANTOPRAZOLE SODIUM 74 46 33 68
CLONIDINE HCL 73 39 35 113
METOPROLOL TARTRATE 71 56 36 26
ATORVASTATIN CALCIUM 71 20 36 17
METOPROLOL SUCCINATE 70 59 38 19
RANITIDINE HCL 70 41 38 61
PAROXETINE HCL 69 57 40 65
VENLAFAXINE HCL ER 68 19 41 88
GLIPIZIDE 64 40 42 124
FLUOXETINE HCL 64 43 42 24
VERAPAMIL ER 62 47 44 97
VENTOLIN HFA 62 14 44 172
NAPROXEN 61 18 46 102
ESCITALOPRAM OXALATE 61 44 46 90
CLOPIDOGREL 60 46 48 71
TOPIRAMATE 60 0 48 120
QUETIAPINE FUMARATE 59 35 50 50
BUPROPION HCL SR 58 41 51 106
TAMSULOSIN HCL 57 53 52 27
CYCLOBENZAPRINE HCL 54 0 R 53 60
IBUPROFEN 53 41 54 43
OXYCODONE HCL 52 29 S2 55 32
LANSOPRAZOLE 50 26 56 237
PROAIR HFA 50 33 56 58
ESTRADIOL 50 33 R 56 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 17, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.